We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 3,356 results
  1. Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010–2018

    Purpose

    The German annual drug prescription-report has indicated overuse of proton pump inhibitors (PPIs) for many years; however, little was known...

    Ina-Maria RĂĽckert-Eheberg, Michael Nolde, ... Sebastian-Edgar Baumeister in European Journal of Clinical Pharmacology
    Article Open access 08 December 2021
  2. Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway

    Purpose

    To compare the co-prescription of metoprolol and potent CYP2D6-inhibiting antidepressants before and during a 10-year period after...

    Ane Gedde-Dahl, Olav Spigset, Espen Molden in European Journal of Clinical Pharmacology
    Article Open access 25 July 2022
  3. Precision Medicine in Diabetes

    Tailoring treatment or management to groups of individuals based on specific clinical, molecular, and genomic features is the concept of precision...
    Adem Y. Dawed, Eram Haider, Ewan R. Pearson in Precision Medicine
    Chapter 2022
  4. The prevalence and clinical context of antimicrobial resistance amongst medical inpatients at a referral hospital in Rwanda: a cohort study

    Background

    Antimicrobial resistance (AMR) is a growing global concern. AMR surveillance is a crucial component of the international response;...

    Olivier Bizimungu, Peter Crook, ... LĂ©opold Bitunguhari in Antimicrobial Resistance & Infection Control
    Article Open access 22 February 2024
  5. Ability to detect potentially inappropriate prescribing in older patients: comparative analysis between PIM-Check and STOPP/STARTv2

    Purpose

    Potentially inappropriate prescribing (PIP) is a source of preventable adverse drug events. The objective of this study was a comparative...

    Akram Farhat, Alice Panchaud, ... Chantal Csajka in European Journal of Clinical Pharmacology
    Article Open access 30 June 2021
  6. Antibody-Based Biotherapeutics in Inflammatory Diseases

    Inflammatory diseases encompass a broad and diverse spectrum of serious chronic disorders, many of which have significant need for safe and effective...
    Yan Xu, Jia Chen, Honghui Zhou in Pharmaceutical Biotechnology
    Chapter 2024
  7. Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data

    Purpose

    To investigate real-world prescribing trends and clinical outcomes based on body mass index (BMI) categorization in patients who received...

    Majdoleen Alalawneh, Ousama Rachid, ... Ahmed Awaisu in European Journal of Clinical Pharmacology
    Article Open access 10 October 2023
  8. Economic Evidence for Pharmacist Prescribing in Community Pharmacy

    The effectiveness of pharmacist interventions is supported by high-level evidence from around the world. Such effectiveness combined with high levels...
    Living reference work entry 2023
  9. Missing PPI prescriptions while overprescribing?

    Ingrid Schubert, Veronika Lappe, ... Daniel Grandt in European Journal of Clinical Pharmacology
    Article Open access 19 September 2023
  10. Current Trends and Future Directions in Urban Social Prescribing

    Purpose of Review

    Social prescribing (SP) is defined as a non-medical community referral program to support well-being and health. This review...

    J. S. Litt, L. Coll-Planas, ... M. Howarth in Current Environmental Health Reports
    Article 13 December 2023
  11. Factors associated with long-term benzodiazepine and Z-drug use across the lifespan and 5-year temporal trajectories among incident users: a Swedish nationwide register-based study

    Purpose

    Despite being discouraged by guidelines, long-term use of benzodiazepines and related Z-drugs (BZDR) remains frequent in the real-world. An...

    Kayoko Isomura, **nchen Wang, ... Anna Sidorchuk in European Journal of Clinical Pharmacology
    Article Open access 09 June 2023
  12. The impact of a summative national prescribing assessment and curriculum type on the development of the prescribing competence of junior doctors

    Purpose

    The primary aim of this study was to investigate the effect of including the Dutch National Pharmacotherapy Assessment (DNPA) in the medical...

    Erik M. Donker, Hayaudin Osmani, ... Jelle Tichelaar in European Journal of Clinical Pharmacology
    Article Open access 22 September 2023
  13. Inequalities in the provision of GLP-1 receptor agonists for the treatment of obesity

    Stephanie W. Waldrop, Veronica R. Johnson, Fatima Cody Stanford in Nature Medicine
    Article 03 January 2024
  14. The impact of the COVID-19 pandemic on the treatment of common infections in primary care and the change to antibiotic prescribing in England

    Background

    There is concern that the COVID-19 pandemic altered the management of common infections in primary care. This study aimed to evaluate...

    Ya-Ting Yang, **aomin Zhong, ... Victoria Palin in Antimicrobial Resistance & Infection Control
    Article Open access 16 September 2023
  15. Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014–2022)

    Purpose

    To investigate trends in SGLT2i and GLP-1RA use in Australia in the era of increased evidence of their cardiovascular benefits.

    ...
    Jialing Lin, Sallie-Anne Pearson, ... Juliana de Oliveira Costa in European Journal of Clinical Pharmacology
    Article Open access 14 July 2023
  16. Unveiling the Biosimilar Paradox of Oncologists’ Perceptions and Hesitations in South Korea: A Web-Based Survey Study

    Introduction

    Biosimilars offer a cost-effective alternative to original biopharmaceuticals with comparable efficacy and safety. The perception and...

    Gyeongseon Shin, Byung Soo Kim, ... Seung** Bae in BioDrugs
    Article Open access 12 January 2024
  17. Patient perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care: a qualitative description study

    Many patients with major depressive disorder (MDD) try multiple antidepressants before finding one that works well and is tolerable. Pharmacogenomic...

    Alexandra Cernat, Zainab Samaan, ... Meredith Vanstone in Journal of Community Genetics
    Article 08 April 2024
  18. Deprescribing

    Deprescribing refers to reducing or stop** medications that may no longer be needed, may be causing more harm than good, or may not align with a...
    Living reference work entry 2023
  19. Gamified antimicrobial decision support app (GADSA) changes antibiotics prescription behaviour in surgeons in Nigeria: a hospital-based pilot study

    Aims

    Surgical Antibiotic Prophylaxis (SAP) in Nigeria is often not evidence based. The aim of this study is to test if the GADSA application can...

    Susanne Luedtke, Caroline Wood, ... Patty Kostkova in Antimicrobial Resistance & Infection Control
    Article Open access 06 December 2023
  20. Prescription characteristics associated with drug overdose risk among adults prescribed benzodiazepines: a cohort study

    Background

    Drug overdose (OD) deaths in the U.S. continue to rise. After opioids, benzodiazepines (BZD) are the medication most commonly involved in...

    Donovan T. Maust, Amy S. B. Bohnert, ... Jason E. Goldstick in BMC Pharmacology and Toxicology
    Article Open access 19 May 2023
Did you find what you were looking for? Share feedback.